Table 4.
Logistic regression analysis for factors associated with osteoporosis in the 142 male patients with CP
| Univariatea | Multivariatea | |||
|---|---|---|---|---|
| OR (95% CI) | P-value | OR (95% CI) | P-value | |
| Age (per increasing year) | 1.04 (0.99–1.09) | 0.06 | – | |
| BMI (per increasing unit) | 0.84 (0.72–0.97) | 0.02 | 0.85 (0.71–1.03) | 0.11 |
| PTH (per increasing increasing unit) | 1.01 (1.00–1.03) | 0.04 | 1.01 (0.99–1.03) | 0.22 |
| Vitamin D deficiency | 1.14 (0.38–3.44) | 0.81 | – | |
| Vitamin K deficiency | 4.25 (1.27–14.2) | 0.01 | 5.28 (1.31–21.40) | 0.01 |
| CRP (per increasing unit) | 0.84 (0.59–1.21) | 0.36 | – | |
| Faecal elastase (per increasing unit) | 1.00 (0.99–1.00) | 0.29 | – | |
| Diabetes | 0.47 (0.15–1.47) | 0.19 | – | |
| Active smoking | 1.45 (0.48–4.35) | 0.50 | – | |
| Advanced-marked disease | 0.52 (0.10–2.67) | 0.44 | ||
| Alcholic aetiology | 1.04 (0.37–2.94) | 0.93 | – | |
| Disease duration (per year) | 1.00 (0.99–1.00) | 0.81 | – | |
| PERT | 0.82 (0.31–2.11) | 0.68 | – | |
BMI body mass index, PTH parathormone, CRP C-reactive protein, PERT pancreatic enzyme replacement therapy
aAdjusted for centre of enrolment